Unknown

Dataset Information

Clinical experience with insulin detemir in patients with type 2 diabetes from the near East countries.


ABSTRACT:

Introduction

This study aimed at determining the clinical safety and efficacy of insulin detemir (IDet) in combination with oral anti-diabetic drugs (OADs) in type 2 diabetes (T2D) patients from four Near East Countries (Israel, Jordan, Pakistan and Lebanon).

Methods

This prospective observational study included T2D patients previously on OADs and newly diagnosed patients initiating IDet with or without OADs, at the discretion of physicians. Safety objectives included evaluation of hypoglycemia and adverse drug reactions (ADRs) from baseline to Week 24. Efficacy outcomes included baseline to Week 24 changes in glucose control parameters (glycated hemoglobin [HbA1c], fasting plasma glucose [FPG] and post-breakfast post-prandial plasma glucose [PPPG]). Change in body weight du

SUBMITTER: Echtay A 

PROVIDER: S-EPMC3889319 | biostudies-literature | 2013 Dec

REPOSITORIES: biostudies-literature